1. Merikangas KR, Akiskal HS, Angst J, Greenberg PE, Hirschfeld RM, Petukhova M, et al. Lifetime and 12-month prevalence of bipolar spectrum...
2. Merikangas KR, Jin R, He JP, Kessler RC, Lee S, Sampson NA, et al. Prevalence and correlates of bipolar spectrum disorder in the world...
3. Stubbs B, Vancampfort D, Solmi M, Veronese N, Fornaro M. How common is bipolar disorder in general primary care attendees? A systematic...
4. Krishnan KR. Psychiatric and medical comorbidities of bipolar disorder. Psychosom Med. 2005;67:1---8.
5. Ferrari AJ, Stockings E, Khoo JP, Erskine HE, Degenhardt L, Vos T, et al. The prevalence and burden of bipolar disorder: findings from...
6. Hauser M, Galling B, Correll CU. Suicidal ideation and suicide attempts in children and adolescents with bipolar disorder: a systematic...
7. Goffin KC, Dell’Osso B, Miller S, Wang PW, Holtzman JN, Hooshmand F, et al. Different characteristics associated with suicide attempts...
8. Kaufman KR. Comparative bioethics in bipolar and epilepsy research. Seizure. 2002;11:51---6.
9. World Anti-Doping Agency. World Anti-Doping Code 2015. Available at: https://www.wada-ama.org/sites/default/ files/resources/files/wada-2015-world-anti-doping-code.pdf...
10. World Anti-Doping Agency. World Anti-Doping Code: The 2017 Prohibited List International Standard. Available at: https://www.wada-ama.org/sites/default/files/resources/...
11. Kaufman KR. Anticonvulsants in sports: ethical considerations. Epilepsy Behav. 2007;10:268---71.
12. Kaufman KR. Antiepileptic drugs in the treatment of psychiatric disorders. Epilepsy Behav. 2011;21:1---11.
13. Kaufman KR. Modafinil in sports: ethical considerations. Br J Sports Med. 2005;39:241---4.
14. World Anti-Doping Agency. World Anti-Doping Code: International Standard for Therapeutic Use Exemptions. Available at: https://www.wada-ama.org/sites/default/files/resources/...
15. Joslyn C, Hawes DJ, Hunt C, Mitchell PB. Is age of onset associated with severity, prognosis, and clinical features in bipolar disorder?...
16. Nabavi B, Mitchell AJ, Nutt D. A lifetime prevalence of comorbidity between bipolar affective disorder and anxiety disorders: a meta-analysis...
17. Perroud N, Cordera P, Zimmermann J, Michalopoulos G, Bancila V, Prada P, et al. Comorbidity between attention deficit hyperactivity disorder...
18. Simhandl C, Radua J, König B, Amann BL. Prevalence and impact of comorbid alcohol use disorder in bipolar disorder: a prospective follow-up...
19. Nesvåg R, Knudsen GP, Bakken IJ, Høye A, Ystrom E, Surén P, et al. Substance use disorders in schizophrenia, bipolar disorder, and depressive...
20. Okuda M, Picazo J, Olfson M, Hasin DS, Liu SM, Bernardi S, et al. Prevalence and correlates of anger in the community: results from a...
21. Perlis RH, Smoller JW, Fava M, Rosenbaum JF, Nierenberg AA, Sachs GS. The prevalence and clinical correlates of anger attacks during depressive...
22. Tondo L, Isacsson G, Baldessarini R. Suicidal behaviour in bipolar disorder: risk and prevention. CNS Drugs. 2003;17:491---511.
23. Schaffer A, Isometsä ET, Tondo L, Moreno DH, Sinyor M, Kessing LV, et al. Epidemiology, neurobiology and pharmacological interventions...
24. Gonda X, Pompili M, Serafini G, Montebovi F, Campi S, Dome P, et al. Suicidal behavior in bipolar disorder: epidemiology, characteristics...
25. Cipriani A, Hawton K, Stockton S, Geddes JR. Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis....
26. Baldessarini RJ, Tondo L, Davis P, Pompili M, Goodwin FK, Hennen J. Decreased risk of suicides and attempts during longterm lithium treatment:...
27. Baldessarini RJ, Tondo L, Hennen J. Effects of lithium treatment and its discontinuation on suicidal behavior in bipolar manicdepressive...
28. Reardon CL, Factor RM. Sport psychiatry: a systematic review of diagnosis and medical treatment of mental illness in athletes. Sports...
29. Reardon CL, Creado S. Psychiatric medication preferences of sports psychiatrists. Phys Sportsmed. 2016;44:397---402.
30. Rosenbaum S, Tiedemann A, Sherrington C, Curtis J, Ward PB. Physical activity interventions for people with mental illness: a systematic...
31. Capovilla G, Kaufman KR, Perucca E, Moshé SL, Arida RM. Epilepsy, seizures, physical exercise, and sports: a report from the ILAE Task...
32. Malhi GS, Byrow Y. Exercising control over bipolar disorder. Evid Based Ment Health. 2016;19:103---5.
35. Fédération Internationale de Gymnastique. 2017---2020 Code of Points: Women’s Artistic Gymnastics. Available at: http://www.fig-gymnastics.com/publicdir/rules/files/wag/...
36. Zesiewicz TA, Elble R, Louis ED, Hauser RA, Sullivan KL, Dewey RB Jr, et al. Practice parameter: therapies for essential tremor: report...
37. Zesiewicz TA, Elble RJ, Louis ED, Gronseth GS, Ondo WG, Dewey RB Jr, et al. Evidence-based guideline update: treatment of essential tremor:...
50. World Anti-Doping Agency. World Anti-Doping Code: The 2017 Monitoring Program. Available at: https://www.wada-ama.org/ sites/default/files/resources/files/2016-09-29...
51. Baume N, Jan N, Emery C, Mandanis B, Schweizer C, Giraud S, et al. Antidoping programme and biological monitoring before and during the...
52. Hochberg MC, Altman RD, April KT, Benkhalti M, Guyatt G, McGowan J, et al. American College of Rheumatology 2012 recommendations for the...
53. Lynch ME, Campbell F. Cannabinoids for treatment of chronic non-cancer pain; a systematic review of randomized trials. Br J Clin Pharmacol....
54. La Porta C, Bura SA, Negrete R, Maldonado R. Involvement of the endocannabinoid system in osteoarthritis pain. Eur J Neurosci. 2014;39:485---500.
